HealthQuad has made a strategic investment in LifeSigns to enhance its AI-driven remote patient monitoring platform, aiming for growth in Southeast Asia and GCC markets.
This investment will bolster LifeSigns' predictive care technology through targeted AI integrations. HealthQuad, part of the Quadria Group, is focused on advancing healthcare delivery from episodic to continuous monitoring, emphasizing the importance of predictive intelligence in modern healthcare systems.
LifeSigns has created a US FDA-approved platform that integrates wearable devices with a cloud-based dashboard and an AI engine capable of identifying early signs of patient deterioration. The platform is currently in use across various healthcare settings, including ambulances and ICU units, and can monitor vital signs such as ECG and blood pressure. Notably, its AI technology can predict patient decline up to 26 hours in advance.
With deployments in over 50 hospitals in India, LifeSigns has reported significant improvements, including a nearly 90% reduction in code blue incidents and a 78% decrease in ICU readmissions. The company’s focus on tier 2 cities and a centralized monitoring command center underscores its commitment to expanding access to predictive care.
This investment not only marks HealthQuad's first institutional backing of LifeSigns but also opens avenues for global market expansion, as healthcare increasingly shifts towards continuous monitoring solutions amid rising costs and workforce challenges.